Company · Ownership research

LIGAND PHARMACEUTICALS INC LGND

CIK 0000886163

Form 4 transactions dated Nov 1, 2023 to Nov 10, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 56 rows; the complete set is available through the API.

Insider filings on file run through Nov 4, 2026.

Insider purchases & sales

Purchased: $1.40M
Sold: $49.97M

Nov 1, 2023 – Nov 4, 2026
Available records · partial months are marked ·

202510 of 16 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 12, 2025	Espinoza Octavio Chief Financial Officer	Sale	$339.71K 1,804 shares sold	6.45% sold Direct holding	▾
Dec 1, 2025	KOZARICH JOHN W Director	Sale10b5-1 footnote	$91.46K 467 shares sold	1.05% sold Direct holding	▾
Nov 7, 2025	Gray Nancy Ryan Director	Sale	$1.35M 6,571 shares sold	Unavailable Direct holding	▾
Nov 7, 2025	LAMATTINA JOHN L Director	Sale	$858.58K 4,179 shares sold	Unavailable Direct holding	▾
Nov 3, 2025	KOZARICH JOHN W Director	Sale10b5-1 footnote	$89.22K 467 shares sold	1.04% sold Direct holding	▾
Oct 1, 2025	KOZARICH JOHN W Director	Sale10b5-1 footnote	$83.80K 467 shares sold	1.03% sold Direct holding	▾
Sep 23, 2025	Aryeh Jason Director	Sale	$1.71M 10,000 shares sold	12.61% sold Direct holding	▾
Sep 2, 2025	KOZARICH JOHN W Director	Sale10b5-1 footnote	$75.77K 467 shares sold	1.02% sold Direct holding	▾
Aug 1, 2025	KOZARICH JOHN W Director	Sale10b5-1 footnote	$61.59K 467 shares sold	1.01% sold Direct holding	▾
Jul 10, 2025	KOZARICH JOHN W Director	Sale10b5-1 footnote	$116.75K 934 shares sold	1.97% sold Direct holding	▾

Showing 16 / 16 record groups in 2025. The complete set is available through the API.

LIGAND PHARMACEUTICALS INC · LGND

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 16 of 16 purchase / sale groups and 30 of 56 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"LGND","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.